Neonatal Sepsis: Diagnostic Evaluation & Management Learning Tool

Clinical History Assessment

Systematic approach to history taking for a neonate with suspected sepsis

Physical Examination Guide

Systematic approach to examining a neonate with suspected sepsis

Diagnostic Approach

Initial Assessment

For a neonate presenting with suspected sepsis, the initial assessment should include:

• Thorough history of maternal, birth, and neonatal risk factors
• Complete physical examination focusing on signs of infection
• Immediate laboratory studies and cultures
• Assessment of vital signs and hemodynamic stability

Classification of Neonatal Sepsis

Neonatal sepsis is classified based on timing of onset:

Classification	Definition	Key Features
Early-Onset Sepsis (EOS)	Onset within first 72 hours of life	Maternal transmission, often rapid progression, commonly caused by GBS and E. coli
Late-Onset Sepsis (LOS)	Onset after 72 hours of life until 28 days	Hospital-acquired or community-acquired pathogens, more localized infections, commonly caused by coagulase-negative staphylococci
Very Late-Onset Sepsis	Onset after 28 days of life (especially in preterm infants)	Often seen in prolonged NICU stays, associated with invasive procedures and devices

Differential Diagnosis

System	Conditions	Red Flags
Infectious	- Bacterial sepsis - Viral infections (HSV, enteroviruses) - Fungal sepsis - Meningitis - Pneumonia - Urinary tract infection	- Temperature instability - Poor feeding - Respiratory distress - Jaundice - Hepatosplenomegaly
Metabolic	- Inborn errors of metabolism - Hypoglycemia - Electrolyte disturbances - Congenital adrenal hyperplasia	- Rapidly deteriorating clinical status - Metabolic acidosis - Seizures - Family history of metabolic disorders - Ambiguous genitalia
Cardiac	- Congenital heart disease - Cardiomyopathy - Arrhythmias - Myocarditis	- Cyanosis - Poor perfusion - Heart murmur - Hepatomegaly - Unexplained shock
Neurologic	- Hypoxic-ischemic encephalopathy - Intracranial hemorrhage - Seizure disorders - Kernicterus	- Seizures - Abnormal tone - Lethargy - Bulging fontanelle - Severe hyperbilirubinemia
Respiratory	- Respiratory distress syndrome - Transient tachypnea of newborn - Meconium aspiration syndrome - Pneumothorax	- Tachypnea - Retractions - Grunting - Nasal flaring - Asymmetric breath sounds

Laboratory Studies

Core laboratory tests for evaluation of neonatal sepsis:

Investigation	Clinical Utility	Interpretation
Complete Blood Count (CBC)	Assess for evidence of infection or inflammation	- WBC count: Leukopenia (<5000 /mm³) or leukocytosis (>20,000/mm³) - Neutropenia (<1500 /mm³) or neutrophilia - Immature-to-total neutrophil ratio (I:T) >0.2 - Thrombocytopenia (<150,000 /mm³)
Blood Culture	Gold standard for diagnosis of bacteremia	- Obtain before antibiotics when possible - Minimum 1 mL of blood (ideally 2 mL) - Consider two cultures from separate sites in LOS
C-Reactive Protein (CRP)	Acute phase reactant, peaks at 24-48 hours	- Serial measurements more useful than single value - Low sensitivity at onset (<12 hours) - Persistently normal CRP at 24-48 hours has high negative predictive value
Procalcitonin (PCT)	Earlier marker of bacterial infection	- Rises earlier than CRP (4-6 hours) - Physiologic rise in first 24-48 hours of life - More specific than CRP
Cerebrospinal Fluid (CSF) Analysis	Diagnose meningitis	- Consider in all neonates with suspected sepsis - Interpret with normative values for gestational age - May be deferred if critically unstable

Additional Studies

Consider these additional tests based on clinical presentation:

Investigation	Clinical Utility	When to Consider
Urinalysis and Culture	Diagnose urinary tract infection	Late-onset sepsis, unexplained fever, urinary symptoms
Chest X-ray	Evaluate for pneumonia or other pulmonary pathology	Respiratory symptoms, oxygen requirement, apnea
Abdominal X-ray	Diagnose intestinal pathology	Abdominal distension, bilious vomiting, bloody stools
Serum Electrolytes, BUN, Creatinine	Assess fluid status and renal function	Poor feeding, dehydration, oliguria
Liver Function Tests	Evaluate hepatic involvement	Jaundice, hepatomegaly, coagulopathy
Coagulation Studies	Assess for disseminated intravascular coagulation (DIC)	Bleeding, petechiae, purpura, shock
Blood Gas Analysis	Evaluate acid-base status and oxygenation	Respiratory distress, shock, metabolic derangement
PCR Testing	Rapid detection of specific pathogens	Suspected HSV, enteroviruses, or resistant organisms

Diagnostic Algorithm

A stepwise approach to diagnosing neonatal sepsis:

1. Risk Assessment: Evaluate maternal, birth, and neonatal risk factors
2. Clinical Evaluation: Complete physical examination and vital signs assessment
3. Obtain Cultures: Blood culture and other cultures as indicated
4. Laboratory Studies: CBC with differential, CRP, PCT, and other labs as needed
5. Imaging: Chest X-ray and/or other imaging based on clinical presentation
6. Lumbar Puncture: Consider CSF analysis if stable enough for procedure
7. Empiric Antibiotic Therapy: Initiate while awaiting culture results
8. Serial Monitoring: Regular reassessment of clinical status and laboratory markers
9. Narrow Therapy: Target antibiotics based on culture results when available

Management Strategies

General Approach to Management

Key principles in managing neonatal sepsis:

• Early Recognition: Prompt identification of at-risk neonates
• Timely Intervention: Rapid institution of appropriate antimicrobial therapy
• Supportive Care: Maintenance of physiologic stability
• Ongoing Monitoring: Serial assessment of response to therapy
• Complication Prevention: Vigilance for potential sequelae

Antimicrobial Therapy

Scenario	Recommended Regimen	Considerations
Early-Onset Sepsis (EOS)	- Ampicillin + Gentamicin - Alternative: Ampicillin + Cefotaxime	- Covers GBS and E. coli - Cefotaxime reserved for suspected meningitis or gentamicin contraindication - Consider local resistance patterns - Duration: 10-14 days for culture-positive, 7-10 days for culture-negative
Late-Onset Sepsis (LOS)	- Vancomycin + Gentamicin or Cefotaxime - Alternative: Vancomycin + Cefepime	- Covers CONS, Staph aureus, gram-negative organisms - Consider local antibiogram - Adjust based on culture results - Duration: 10-14 days for bacteremia, 14-21 days for meningitis
Suspected Fungal Sepsis	- Amphotericin B deoxycholate - Alternative: Liposomal amphotericin B or Micafungin	- Consider in very low birth weight infants - Prolonged antibiotic exposure increases risk - Duration: 14-21 days after last positive culture - Ophthalmologic and CNS evaluation required
Suspected Herpes Simplex Virus	- Acyclovir (60 mg/kg/day divided q8h) - Continue standard bacterial coverage until ruled out	- Consider with skin vesicles, seizures, or maternal history - Obtain surface, CSF, and blood PCR - Duration: 14 days for skin/mouth disease, 21 days for CNS/disseminated - Suppressive therapy may be needed after treatment
Necrotizing Enterocolitis (NEC)	- Ampicillin + Gentamicin + Metronidazole - Alternative: Piperacillin-tazobactam + Vancomycin	- Anaerobic coverage essential - Duration: 10-14 days depending on severity - Surgical consultation for pneumoperitoneum/perforation - NPO status with gastric decompression

Supportive Care Interventions

Intervention	Approach	Evidence and Considerations
Fluid Management	- Maintain euvolemia - Monitor fluid balance - Address third spacing	- Frequent assessment of weight, I/Os, electrolytes - Recognize SIADH risk with meningitis - Target urine output 1-3 ml/kg/hr - High-risk for fluid shifts in capillary leak
Respiratory Support	- Oxygen supplementation - Non-invasive support (CPAP) - Mechanical ventilation if needed	- Frequent respiratory decompensation in sepsis - Low threshold for intubation in progressive respiratory failure - Monitor blood gases and oxygen requirements - Consider PPHN in refractory hypoxemia
Hemodynamic Support	- Crystalloid boluses for hypotension - Vasoactive medications - Echocardiography as indicated	- First-line: Normal saline 10-20 ml/kg - Dopamine first-line presssor (5-20 mcg/kg/min) - Epinephrine for refractory shock (0.05-1 mcg/kg/min) - Consider hydrocortisone for catecholamine-resistant shock
Nutrition	- Early parenteral nutrition - Trophic feeds when stable - Advancement as tolerated	- NPO often indicated initially - Careful reintroduction of enteral feeds - Monitor for feeding intolerance - Protein and calorie needs increased in sepsis
Hematologic Support	- RBC transfusions - Platelet transfusions - Fresh frozen plasma as indicated	- RBC transfusion for Hgb <8-10 g/dL based on clinical status - Platelet transfusion for count <20-50K based on bleeding risk - FFP for active bleeding with coagulopathy - Monitor for transfusion reactions

Adjunctive Therapies

Therapy	Indications	Evidence and Recommendations
Intravenous Immunoglobulin (IVIG)	- Adjunctive therapy in proven sepsis - Very low birth weight infants - Refractory septic shock	- Not recommended routinely - Conflicting evidence on efficacy - Consider in select cases with hypogammaglobulinemia - Typical dose: 500-1000 mg/kg
Granulocyte Colony Stimulating Factor (G-CSF)	- Severe neutropenia - Sepsis with neutrophil dysfunction	- Limited evidence for routine use - May consider in neutropenia (ANC <1000 /mm³) - Typical dose: 5-10 mcg/kg/day - Monitor white cell counts
Exchange Transfusion	- Severe sepsis with DIC - Refractory septic shock - Severe neutropenia	- Reserved for severe, refractory cases - Limited evidence but may provide fresh clotting factors and remove toxins - High procedural risk - Consider in consultation with hematology
Pentoxifylline	- Adjunctive therapy for sepsis - Preterm infants with sepsis	- TNF-α inhibitor with anti-inflammatory properties - Some evidence for reduced mortality in preterm sepsis - Not standard of care in most centers - Research ongoing

Monitoring and Duration of Therapy

Parameter	Monitoring Approach	Decision Points
Clinical Assessment	- Vital signs q1-4h - Perfusion assessment - Activity and tone - Feeding tolerance	- Improvement in first 24-48 hours expected - Persistent abnormalities warrant reevaluation - Development of new symptoms requires investigation - Cardiorespiratory stability needed before de-escalation
Laboratory Monitoring	- Serial CBCs q24-48h - CRP at 24-48h intervals - Renal and liver function as indicated - Repeat blood cultures for persistent fever	- Normalizing CRP supports treatment response - Persistent abnormalities may indicate inadequate therapy - Drug levels for toxicity monitoring (gentamicin, vancomycin) - Negative repeat cultures allow narrowing of therapy
Antimicrobial Duration	- Based on pathogen, site, clinical response - Reassess need daily - De-escalate when appropriate	- Culture-positive sepsis: 10-14 days - Culture-negative clinical sepsis: 7-10 days - Meningitis: 14-21 days - Fungal sepsis: minimum 14 days after last positive culture
Follow-up Studies	- Repeat LP for meningitis - Imaging for focal infections - Hearing screening before discharge	- LP not routinely repeated if uncomplicated course - End-of-therapy imaging for abscesses or endocarditis - Neurodevelopmental follow-up for meningitis cases - Auditory brainstem response testing for meningitis

Prevention Strategies

Strategy	Implementation	Evidence and Recommendations
Maternal GBS Prophylaxis	- Universal GBS screening at 35-37 weeks - IAP for positive mothers or risk factors - Adequate dosing (≥4 hours before delivery)	- Strong evidence for EOS prevention - Penicillin G preferred agent - Clindamycin for PCN allergy with susceptible strain - Vancomycin for resistant strains or severe allergy
Infection Control Practices	- Hand hygiene - Central line care bundles - Skin antisepsis protocols - Minimal handling strategies	- Critical for LOS prevention - Hand hygiene most important measure - CHG for line insertion in ≥34 weeks GA - Daily evaluation of line necessity
Feeding Practices	- Human milk feeding - Standardized feeding protocols - Donor milk when maternal milk unavailable - Probiotics consideration	- Human milk reduces NEC and LOS risk - Standardized feeding advancement reduces NEC - Probiotic evidence strongest for NEC prevention - Avoid rapid feed advancement
Antifungal Prophylaxis	- Fluconazole prophylaxis - Target ELBW infants - High-risk NICU settings	- Effective for invasive candidiasis prevention - Consider in <1000g birth weight - Typical regimen: 3-6 mg/kg twice weekly - Duration through central line presence or 6 weeks
Antibiotic Stewardship	- Empiric duration limitations - Daily antibiotic review - Narrow spectrum when possible - Guidelines for prolongation	- Extended courses increase NEC/LOS/mortality risk - Stop antibiotics at 36-48h if cultures negative and clinically well - Avoid unnecessary broad-spectrum agents - Monitor antibiotic days and compliance with guidelines

Long-term Follow-up and Outcomes

• Neurodevelopmental Outcomes: Higher risk for developmental delay, cerebral palsy, and hearing loss in survivors, especially with meningitis
• Growth: Monitor for adequate catch-up growth, especially in preterm infants
• Hearing: Universal newborn hearing screening plus follow-up ABR for meningitis cases
• Neuroimaging: Consider MRI for infants with meningitis or abnormal neurologic exam
• Developmental Surveillance: Close follow-up with standardized assessments, particularly in high-risk infants
• Family Support: Education on warning signs, developmental milestones, and available resources

When to Refer

• Infectious Disease Consultation: Complex or unusual pathogens, meningitis, treatment failure
• Neurology: Seizures, abnormal neurologic exam, or meningitis
• Surgery: NEC with pneumoperitoneum, abscesses requiring drainage
• Cardiology: Persistent pulmonary hypertension, hemodynamic instability despite pressors
• Nephrology: Acute kidney injury, fluid/electrolyte management challenges
• Developmental Specialists: Early intervention services for high-risk infants
• Transfer to Higher Level of Care: For infants requiring support beyond current facility capabilities

---

Brief Theory

Comprehensive Guide to Neonatal Sepsis Overview & Definition Epidemiology & Risk Factors Pathophysiology Clinical Presentation Diagnosis & Workup Management & Treatment Complications Prevention Strategies Prognosis & Outcomes Recent Advances & Future Directions

Overview & Definition of Neonatal Sepsis

Neonatal sepsis is a systemic inflammatory response syndrome (SIRS) occurring in infants ≤28 days of life, caused by a suspected or proven infection. It is categorized into:

• Early-onset sepsis (EOS): Occurs within first 72 hours of life
• Late-onset sepsis (LOS): Occurs after 72 hours up to 28 days of life

The condition remains a significant cause of morbidity and mortality in newborns worldwide, particularly in developing countries.

Epidemiology & Risk Factors

Global Burden:

Current global estimates indicate:

• Incidence: 1-5 per 1000 live births in developed countries
• Mortality: Up to 20-30% in developing countries
• Higher rates in premature and very low birth weight infants

Risk Factors:

Maternal Factors:

• Prolonged rupture of membranes (>18 hours)
• Maternal fever (>38°C)
• Chorioamnionitis
• Group B Streptococcus colonization
• Urinary tract infections

Neonatal Factors:

• Prematurity (<37 weeks gestation)
• Low birth weight (<2500g)
• Invasive procedures
• Prolonged hospital stay

Pathophysiology

The pathophysiology involves complex interactions between:

• Immature immune system response
• Pathogenic organisms
• Environmental factors

Common Pathogens:

Early-onset sepsis:

• Group B Streptococcus
• Escherichia coli
• Listeria monocytogenes

Late-onset sepsis:

• Coagulase-negative Staphylococci
• Staphylococcus aureus
• Gram-negative organisms
• Candida species

Clinical Presentation

Signs and symptoms are often subtle and nonspecific:

• Temperature instability
• Respiratory distress (tachypnea, grunting, retractions)
• Cardiovascular changes (tachycardia, poor perfusion)
• Neurologic symptoms (lethargy, irritability, seizures)
• Feeding intolerance
• Skin changes (mottling, cyanosis)

Diagnosis & Workup

Essential Diagnostic Tests:

Current diagnostic approach includes:

• Complete Blood Count (CBC):
  • White blood cell count: Leukopenia (<5000/μL) or leukocytosis (>20,000/μL)
  • Immature-to-total neutrophil ratio >0.2
  • Platelet count: Thrombocytopenia (<100,000/μL)
• Blood Culture:
  • Gold standard for diagnosis
  • Minimum 1mL blood sample recommended
  • Results typically available in 24-48 hours
• Inflammatory Markers:
  • C-reactive protein (CRP): >10 mg/L suggests infection
  • Procalcitonin: >2 ng/mL highly suggestive of bacterial infection

Additional Investigations:

Test Category	Specific Tests	Clinical Significance
CSF Analysis	Cell count, glucose, protein, culture	Required if meningitis suspected
Chest Imaging	X-ray, ultrasound	Identifies pneumonia, effusions
Urine Studies	Culture, microscopy	Essential in late-onset sepsis

Management & Treatment

Current Treatment Protocol:

1. Antimicrobial Therapy:

• Early-onset Sepsis:
  • Ampicillin + Gentamicin (first-line)
  • Alternative: Ampicillin + Cefotaxime (if meningitis suspected)
• Late-onset Sepsis:
  • Vancomycin + Gentamicin/Amikacin
  • Adjust based on local resistance patterns

2. Supportive Care:

• Respiratory Support:
  • Oxygen therapy
  • Mechanical ventilation if needed
  • Continuous monitoring of respiratory status
• Hemodynamic Support:
  • Fluid resuscitation (10-20 mL/kg crystalloid)
  • Inotropic support if needed
  • Blood pressure monitoring
• Nutritional Support:
  • Early enteral feeding when stable
  • Parenteral nutrition if needed

Complications

Neonatal sepsis can lead to several serious complications:

• Neurological Complications:
  • Meningitis
  • Seizures
  • Neurodevelopmental impairment
  • White matter injury
• Systemic Complications:
  • Disseminated intravascular coagulation (DIC)
  • Multiple organ dysfunction syndrome
  • Persistent pulmonary hypertension
• Long-term Sequelae:
  • Cognitive impairment
  • Hearing loss
  • Visual impairment
  • Cerebral palsy

Prevention Strategies

Updated Prevention Guidelines:

• Maternal Interventions:
  • GBS screening at 36-37 weeks gestation
  • Intrapartum antibiotic prophylaxis
  • Treatment of maternal infections
• Neonatal Care Practices:
  • Hand hygiene protocols
  • Aseptic techniques for procedures
  • Early breast milk feeding
  • Minimal handling protocols in NICU
• Healthcare Setting:
  • Bundle care approaches
  • Regular staff training
  • Surveillance programs

Prognosis & Outcomes

Outcome depends on multiple factors:

• Timing of Diagnosis:
  • Early recognition improves outcomes
  • Delayed treatment increases mortality risk
• Risk Factors:
  • Gestational age
  • Birth weight
  • Causative organism
  • Associated complications

Current Survival Rates:

• Term infants: >90% survival with appropriate treatment
• Preterm infants: Variable, depending on gestational age and complications
• Mortality higher in developing countries (15-40%)

Recent Advances & Future Directions

Emerging Diagnostic Tools:

• Molecular Diagnostics:
  • PCR-based rapid diagnostics
  • Next-generation sequencing
  • Point-of-care testing devices
• Biomarker Research:
  • Novel inflammatory markers
  • Metabolomic profiles
  • Proteomics-based approaches

Treatment Advances:

• Immunotherapy:
  • Monoclonal antibodies
  • Immunoglobulin therapy
  • Cytokine modulators
• Antibiotic Stewardship:
  • Targeted therapy approaches
  • Duration optimization
  • Resistance prevention strategies